Huntington's disease

Journal of Clinical Pathology - Molecular Pathology

Volumn 54, Issue 6, 2001, Pages 409-413

  Davies, S ^a   Ramsden, D B ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Huntingtin; Huntington's disease; Kainate receptors; Neurodegenerative disorder; NMDA receptors

Indexed keywords

EXCITOTOXIN; HUNTINGTIN; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

APOPTOSIS; CELL NUCLEUS; DISEASE MODEL; HUMAN; HUNTINGTON CHOREA; MEDICAL RESEARCH; NERVE CELL NECROSIS; NEUROPATHOLOGY; NEUROTOXICITY; PRIORITY JOURNAL; REVIEW; TRINUCLEOTIDE REPEAT;

EID: 0035668372     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.54.6.409     Document Type: Review

References (60)

1. Recent advances in understanding the pathogenesis of Huntington's disease
2. Neurobiology of Huntington's disease
3. Molecular basis of the neurodegenerative disorders
4. The molecular biology of Huntington's disease
5. Huntington's disease: The challenge for cell biologists
6. The pattern of neurodegeneration in Huntington's disease: A comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease
7. Movement disorders
8. A polymorphic DNA marker genetically linked to Huntington's disease
9. The status of SCA1, MJD/SCA3, FRDA, DRPLA and MD triplet containing genes in patients with Huntington disease and healthy controls
10. Gender of the embryo contributes to CAG instability in transgenic mice containing a Huntington's disease gene
11. Dramatic mutation instability in HD mouse striatum: Does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease?
12. Transcriptional dysregulation in Huntington's disease
13. Huntingtin: An iron-regulated protein essential for normal nuclear and perinuclear organelles
14. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
15. HEAT repeats in Huntington's disease protein
16. Loss of normal huntingtin function: New developments in Huntington's disease research
17. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons
18. Recent advances on the pathogenesis of Huntington's disease
19. Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice
20. Dominant phenotypes produced by the HD mutation in STH-dh(Q111) striatal cells
21. Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release
22. Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: Their role in suppression of aggregation and cellular toxicity
23. Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease
24. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
25. Tissue-specific proteolysis of huntingtin (htt) in human brain: Evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum
26. Huntington disease: New insights on the role of huntingtin cleavage
27. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease
28. Kainate receptors: Subunits, synaptic localization and function
29. Molecular physiology of kainate receptors
30. NMDA receptor subunits: Diversity, development and disease
31. NMDA receptors in the basal ganglia
32. Glutamate, but not dopamine, stimulates stress-activated protein kinase and AP-1-mediated transcription in striatal neurons
33. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene
34. Changes in mRNA for post-synaptic density-95 (PSD-95) and carboxy-terminal PDZ ligand of neuronal nitric oxide synthase following facial nerve transection
35. Polyglutamineexpanded huntingtin promotes sensitization of N-methylD-aspartate receptors via post-synaptic density 95
36. Kainate receptor activation induces mixed lineage kinase-mediated cellular signaling cascades via post-synaptic density protein 95
37. Distinct influx pathways, not calcium load, determine neuronal vulnerability to calcium neurotoxicity
38. Activation of MLK2-mediated signaling cascades by polyglutamine-expanded huntingtin
39. Expression of polyglutamine-expanded huntingtin activates the SEK1-JNK pathway and induces apoptosis in a hippocampal neuronal cell line
40. Activated JNK phosphorylates the c-terminal domain of MLK2 that is required for MLK2-induced apoptosis
41. Early degenerative changes in transgenic mice expressing mutant huntingtin involve dendritic abnormalities but no impairment of mitochondrial energy production
42. Brain-derived neurotrophic factor in Huntington disease
43. Intracerebral implantation of NGF-releasing biodegradable microspheres protects striatum against excitotoxic damage
44. No evidence for increased oxidative damage to lipids, proteins, or DNA in Huntington's disease
45. Isoprostanes, novel markers of oxidative injury, help understanding the pathogenesis of neurodegenerative diseases
46. Proton magnetic resonance spectroscopy of cerebrospinal fluid in neurodegenerative disease: Indication of glial energy impairment in Huntington chorea, but not Parkinson disease
47. Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy
48. Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine
49. Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease
50. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription
51. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity
52. Protein kinase C beta II mRNA levels decrease in the striarum and cortex of transgenic Huntington's disease mice
53. HIP12 is a non-proapoptotic member of a gene family including HIP1, an interacting protein with huntingtin
54. Forskolin and dopamine D1 receptor activation increase huntingtin's association with endosomes in immortalized neuronal cells of striatal origin
55. Cloning, expression analysis, and chromosomal localization of HIP1R, an isolog of huntingtin interacting protein (HIP1)
56. An actin-binding protein of the Sla2/Huntingtin interacting protein 1 family is a novel component of clathrin-coated pits and vesicles
57. Huntingtin interacting protein 1 induces apoptosis via a novel caspasedependent death effector domain
58. Isolation of a 40-kDa huntingtin-associated protein
59. HIP12 is a nonproapoptotic member of a gene family including HIP1, an interacting protein with huntingtin
60. A one-hit model of cell death in inherited neuronal degenerations